Liquidia (LQDA) Non-Current Assets (2019 - 2026)
Liquidia (LQDA) recorded quarterly Non-Current Assets of $68.5 million in Q1 2026, up 25.57% quarter-over-quarter from $54.5 million in Q4 2025, and up 36.35% on a YoY basis from $50.2 million in Q1 2025.
Liquidia (LQDA) Non-Current Assets (2019 - 2026) Analysis & Trends
Liquidia's Non-Current Assets history runs 8 years deep, the most recent figure standing at $68.5 million for Q1 2026.
- In Q1 2026, Non-Current Assets rose 36.35% year-over-year to $68.5 million; the TTM figure through Mar 2026 stood at $234.1 million (up 42.56% YoY), while the FY2025 annual figure was $54.5 million, up 20.63% from the prior year.
- Non-Current Assets was $68.5 million for Q1 2026 at Liquidia, up from $54.5 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $68.5 million in Q1 2026 to a low of $28.4 million in Q4 2023.
- Historically, Non-Current Assets has averaged $39.0 million across 5 years, with a median of $30.6 million in 2022.
- The sharpest annual moves came in 2022 and 2025: Non-Current Assets retreated 10.08% in 2022, then soared 105.41% in 2025.
- A 5-year view of Non-Current Assets shows it stood at $29.4 million in 2022, then dropped by 3.25% to $28.4 million in 2023, then soared by 59.0% to $45.2 million in 2024, then rose by 20.63% to $54.5 million in 2025, then advanced by 25.57% to $68.5 million in 2026.
- The last three Non-Current Assets figures came in at $68.5 million (Q1 2026), $54.5 million (Q4 2025), and $49.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 26.33 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 8.68 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 3.84 Bn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 2.47 Bn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 9.64 Bn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 2.90 Bn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 1.40 Bn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 1.22 Bn |
| 10 | Liquidia | 5.74 Bn | 5.52 Bn | 121.79 Mn | 68.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 68.48 Mn |
| Dec 31, 2025 | 54.53 Mn |
| Sep 30, 2025 | 49.26 Mn |
| Jun 30, 2025 | 61.83 Mn |
| Mar 31, 2025 | 50.22 Mn |
| Dec 31, 2024 | 45.21 Mn |
| Sep 30, 2024 | 38.67 Mn |
| Jun 30, 2024 | 30.10 Mn |
| Mar 31, 2024 | 29.18 Mn |
| Dec 31, 2023 | 28.43 Mn |
| Sep 30, 2023 | 28.66 Mn |
| Jun 30, 2023 | 28.71 Mn |
| Mar 31, 2023 | 29.23 Mn |
| Dec 31, 2022 | 29.39 Mn |
| Sep 30, 2022 | 29.51 Mn |
| Jun 30, 2022 | 30.58 Mn |
| Mar 31, 2022 | 31.57 Mn |
| Dec 31, 2021 | 32.45 Mn |
| Sep 30, 2021 | 32.82 Mn |
| Jun 30, 2021 | 33.06 Mn |